Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions.

Miller AC, Comellas AP, Hornick DB, Stoltz DA, Cavanaugh JE, Gerke AK, Welsh MJ, Zabner J, Polgreen PM.

Proc Natl Acad Sci U S A. 2020 Jan 21;117(3):1621-1627. doi: 10.1073/pnas.1914912117. Epub 2019 Dec 27.

2.

Income and Other Contributors to Poor Outcomes in US Sarcoidosis Patients.

Harper LJ, Gerke AK, Wang XF, Ribeiro Neto ML, Baughman RP, Beyer K, Drent M, Judson MA, Maier LA, Serchuck L, Singh N, Culver DA.

Am J Respir Crit Care Med. 2019 Dec 11. doi: 10.1164/rccm.201906-1250OC. [Epub ahead of print]

PMID:
31825646
3.

Approach to tapering antisarcoidosis therapy.

Ussavarungsi K, Gerke AK.

Curr Opin Pulm Med. 2019 Sep;25(5):526-532. doi: 10.1097/MCP.0000000000000607.

PMID:
31365387
4.

Interstitial lung disease associated with anti-PM-Scl antibody: A single center experience.

Ussavarungsi K, Nugent K, Gerke AK, Krasowski MD, Tuetken RS, Lenert PS.

Autoimmun Rev. 2019 Sep;18(9):102355. doi: 10.1016/j.autrev.2019.102355. Epub 2019 Jul 16. No abstract available.

PMID:
31323356
5.

Approach to tapering antisarcoidosis therapy.

Ussavarungsi K, Gerke AK.

Curr Opin Pulm Med. 2019 Jul 11. doi: 10.1097/MCP.0000000000000607. [Epub ahead of print]

PMID:
31306162
6.

Sarcoidosis: No longer a benign disease?

Gerke AK.

Respir Med. 2019 Mar;149:28-29. doi: 10.1016/j.rmed.2019.02.002. Epub 2019 Feb 6. No abstract available.

PMID:
30777310
7.

Airway surface liquid from smokers promotes bacterial growth and biofilm formation via iron-lactoferrin imbalance.

Vargas Buonfiglio LG, Borcherding JA, Frommelt M, Parker GJ, Duchman B, Vanegas Calderón OG, Fernandez-Ruiz R, Noriega JE, Stone EA, Gerke AK, Zabner J, Comellas AP.

Respir Res. 2018 Mar 10;19(1):42. doi: 10.1186/s12931-018-0743-x.

8.

Disease Burden and Variability in Sarcoidosis.

Gerke AK, Judson MA, Cozier YC, Culver DA, Koth LL.

Ann Am Thorac Soc. 2017 Dec;14(Supplement_6):S421-S428. doi: 10.1513/AnnalsATS.201707-564OT. Review.

9.

Effect of vitamin D3 on the antimicrobial activity of human airway surface liquid: preliminary results of a randomised placebo-controlled double-blind trial.

Vargas Buonfiglio LG, Cano M, Pezzulo AA, Vanegas Calderon OG, Zabner J, Gerke AK, Comellas AP.

BMJ Open Respir Res. 2017 Jun 4;4(1):e000211. doi: 10.1136/bmjresp-2017-000211. eCollection 2017.

10.

Effects of Coal Fly Ash Particulate Matter on the Antimicrobial Activity of Airway Surface Liquid.

Vargas Buonfiglio LG, Mudunkotuwa IA, Abou Alaiwa MH, Vanegas Calderón OG, Borcherding JA, Gerke AK, Zabner J, Grassian VH, Comellas AP.

Environ Health Perspect. 2017 Jul 5;125(7):077003. doi: 10.1289/EHP876.

11.

A web-based registry for patients with sarcoidosis.

Gerke AK, Tang F, Cozier YC, Lash MT, Schappet J, Phillips E, Polgreen PM.

Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):26-34. Epub 2017 Apr 28.

12.

Comparative Effectiveness of Pharmacologic Interventions for Pulmonary Arterial Hypertension: A Systematic Review and Network Meta-Analysis.

Jain S, Khera R, Girotra S, Badesch D, Wang Z, Murad MH, Blevins A, Schmidt GA, Singh S, Gerke AK.

Chest. 2017 Jan;151(1):90-105. doi: 10.1016/j.chest.2016.08.1461. Epub 2016 Sep 9. Review.

13.

Lower limit of normal based spirometric abnormalities associated with radiographic abnormality in an elderly cohort at low risk for exposure.

Mikulski MA, Gerke AK, Newell JD Jr, Murray AM, Smith CJ, Fuortes LJ.

Int J Occup Environ Health. 2016 Apr;22(2):121-7. doi: 10.1080/10773525.2016.1176328. Epub 2016 May 4.

14.

Increased trend in extracorporeal membrane oxygenation use by adults in the United States since 2007.

Gerke AK, Tang F, Cavanaugh JE, Doerschug KC, Polgreen PM.

BMC Res Notes. 2015 Nov 18;8:686. doi: 10.1186/s13104-015-1678-7.

15.

Inclusion body myositis and sarcoid myopathy: coincidental occurrence or associated diseases.

Sanmaneechai O, Swenson A, Gerke AK, Moore SA, Shy ME.

Neuromuscul Disord. 2015 Apr;25(4):297-300. doi: 10.1016/j.nmd.2014.12.005. Epub 2014 Dec 19.

PMID:
25599912
16.

The high frequency of healthcare use in patients one year prior to a sarcoidosis diagnosis.

Gerke AK, Tang F, Pendergast J, Cavanaugh JE, Polgreen PM.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20;31(3):256-61.

17.

Morbidity and mortality in sarcoidosis.

Gerke AK.

Curr Opin Pulm Med. 2014 Sep;20(5):472-8. doi: 10.1097/MCP.0000000000000080. Review.

18.

Effects of vitamin D supplementation on alveolar macrophage gene expression: preliminary results of a randomized, controlled trial.

Gerke AK, Pezzulo AA, Tang F, Cavanaugh JE, Bair TB, Phillips E, Powers LS, Monick MM.

Multidiscip Respir Med. 2014 Mar 26;9(1):18. doi: 10.1186/2049-6958-9-18.

19.

A microRNA processing defect in smokers' macrophages is linked to SUMOylation of the endonuclease DICER.

Gross TJ, Powers LS, Boudreau RL, Brink B, Reisetter A, Goel K, Gerke AK, Hassan IH, Monick MM.

J Biol Chem. 2014 May 2;289(18):12823-34. doi: 10.1074/jbc.M114.565473. Epub 2014 Mar 25.

20.

Association of hospitalizations for asthma with seasonal and pandemic influenza.

Gerke AK, Yang M, Tang F, Foster ED, Cavanaugh JE, Polgreen PM.

Respirology. 2014 Jan;19(1):116-21. doi: 10.1111/resp.12165.

21.

Predicting chronic obstructive pulmonary disease hospitalizations based on concurrent influenza activity.

Gerke AK, Tang F, Yang M, Foster ED, Cavanaugh JE, Polgreen PM.

COPD. 2013 Oct;10(5):573-80. doi: 10.3109/15412555.2013.777400. Epub 2013 Jul 2.

22.

Agreement between fixed-ratio and lower limit of normal spirometry interpretation protocols decreases with age: is there a need for a new GOLD standard?

Mikulski MA, Gerke AK, Lourens S, Czeczok T, Sprince NL, Laney AS, Fuortes LJ.

J Occup Environ Med. 2013 Jul;55(7):802-8. doi: 10.1097/JOM.0b013e31828b22cc.

PMID:
23787569
23.

An analysis of seasonality of sarcoidosis in the United States veteran population: 2000-2007.

Gerke AK, Tangh F, Yang M, Cavanaugh JE, Polgreen PM.

Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct;29(2):155-8.

24.

Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects.

Foster ED, Cavanaugh JE, Haynes WG, Yang M, Gerke AK, Tang F, Polgreen PM.

Epidemiol Infect. 2013 Apr;141(4):735-44. doi: 10.1017/S0950268812002890. Epub 2013 Jan 3.

25.

Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study.

Gerke AK, Yang M, Tang F, Cavanaugh JE, Polgreen PM.

BMC Pulm Med. 2012 Jul 9;12:19. doi: 10.1186/1471-2466-12-19.

26.

Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expression.

Philibert RA, Sears RA, Powers LS, Nash E, Bair T, Gerke AK, Hassan I, Thomas CP, Gross TJ, Monick MM.

J Leukoc Biol. 2012 Sep;92(3):621-31. doi: 10.1189/jlb.1211632. Epub 2012 Mar 16.

27.

Smoking inhibits the frequency of bronchovascular bundle thickening in sarcoidosis.

Gerke AK, van Beek E, Hunninghake GW.

Acad Radiol. 2011 Jul;18(7):885-91. doi: 10.1016/j.acra.2011.02.015. Epub 2011 May 6.

28.

The immunology of sarcoidosis.

Gerke AK, Hunninghake G.

Clin Chest Med. 2008 Sep;29(3):379-90, vii. doi: 10.1016/j.ccm.2008.03.014. Review.

PMID:
18539233

Supplemental Content

Loading ...
Support Center